Standard BioTools Achieves New Record of the Most Protein Measurements on the Most Sample Types with Expansion of the SomaScan® 11K Platform
Standard BioTools Inc. (LAB)
Company Research
Source: GlobeNewswire
SOUTH SAN FRANCISCO, Calif., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), today announced that the SomaScan® 11K Platform now includes protein measurements on a broader range of sample types, including cerebrospinal fluid (CSF), aqueous humor, tissue homogenates and cell lysates. The SomaScan® Platform provides the largest number of protein measurements and the greatest number of orthogonally confirmed protein reagents in the proteomics industry —11,000 protein measurements simultaneously from sample volumes as low as 55 µl—giving researchers access to half of the human proteome in just one assay. “These new sample types expand the SomaScan11K Platform’s ability to provide important biological insights, supporting translational medicine by advancing research findings into disease causation, clinical pharmacology and drug development,” said Standard BioTools Chief Medical Officer Stephen A. Williams, MD, PhD. “The use of high-throughput proteomics in cer
Show less
Read more
Impact Snapshot
Event Time:
LAB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LAB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LAB alerts
High impacting Standard BioTools Inc. news events
Weekly update
A roundup of the hottest topics
LAB
News
- Spatial Proteomics Market Projected to Reach USD 264.89 Million by 2032, Driven by a Strong 14.6% CAGR | Polaris Market Research [Yahoo! Finance]Yahoo! Finance
- Standard BioTools Appoints Alex Kim as Chief Financial OfficerGlobeNewswire
- Earnings Release: Here's Why Analysts Cut Their Standard BioTools Inc. (NASDAQ:LAB) Price Target To US$3.17 [Yahoo! Finance]Yahoo! Finance
- Standard BioTools Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]Yahoo! Finance
- Standard BioTools Inc. (NASDAQ: LAB) had its price target lowered by analysts at TD Cowen from $2.75 to $2.50. They now have a "buy" rating on the stock.MarketBeat
LAB
Earnings
- 10/30/24 - Beat
LAB
Sec Filings
- 11/21/24 - Form 4
- 11/14/24 - Form SC
- 11/12/24 - Form SC
- LAB's page on the SEC website